MC
CELG

Miles Capital’s Celgene Corp CELG Stock Holding History

Miles Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,199
Closed -$383K – 186
2015
Q4 		$383K Sell
3,199
-98
-3% -$11.3K 0.26% 94
2015
Q3 		$357K Sell
3,297
-77
-2% -$9.55K 0.26% 100
2015
Q2 		$390K Sell
3,374
-259
-7% -$29.6K 0.26% 104
2015
Q1 		$419K Buy
+3,633
New +$434K 0.25% 99

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Miles Capital's CELG Position: Q1 2016 in Review

Miles Capital sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 3,199 shares — an estimated $383K sold.

Miles Capital first reported a position in CELG in Q1 2015 and held it in 4 quarters. The position peaked at $419K in Q1 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • Miles Capital reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
  • Miles Capital sold 3,199 Celgene Corp shares in Q1 2016, an estimated $383K.
  • Miles Capital first reported a position in Celgene Corp in Q1 2015 and held it in 4 quarters.
  • Miles Capital's Celgene Corp position peaked at $419K in Q1 2015.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Miles Capital's 13F filing for Q1 2016, filed 12 May 2016.